Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association of Serum Homocysteine Level with White Matter Microstructural Integrity in a Non-demented Elderly Population
Aging, Dementia, and Behavioral Neurology
P10 - Poster Session 10 (5:30 PM-6:30 PM)
10-008

To investigate whether elevated homocysteine level is associated with damage of white matter microstructural integrity in a community-dwelling population.

Elevated serum homocysteine levels have been associated with increased risk of numerous physical and mental health problems, such as stroke, dementia, and cognitive decline, which indicates underlying neurobiological changes, but their correlation with white matter microstructural integrity is not known.

This study included 1095 participants (mean age: 55.85 ± 9.41 years, 36.9% male) from the community-based Shunyi cohort study. Serum homocysteine levels were measured by latex-enhanced immunoturbidimetry. Four diffusion tensor neuroimaging parameters (ie. fractional anisotropy (FA), mean diffusion (MD), axial diffusivity (AD) and radial diffusivity (RD) were used to represent white matter integrity.


 

Mean homocysteine level was 18.00 μmol/L (interquartile ranges:12.30 μmol/L-18.90 μmol/L). Increased homocysteine level was associated with decreased mean FA values (β=-0.068, p=0.009), increased mean MD values (β= 0.066, p=0.006), increased mean AD values (β= 0.061, p=0.014), increased mean RD values (β= 0.066, p=0.006), even after additional adjusting for white matter hyperintensities and lacunes. Diffusion tensor imaging abnormalities occurred in widespread region of white matter, predominantly in corpus callosum, bilateral corticospinal tract, and bilateral cerebral peduncle.

Our data showed a significant association between serum homocysteine level and white matter integrity independent of traditional small vessel disease markers, implying the potential impact of homocysteine to brain nerve tract.

Authors/Disclosures
Mei-jun Shu
PRESENTER
Mei-jun Shu has nothing to disclose.
Fei-Fei Zhai Fei-Fei Zhai has nothing to disclose.
Fei Han Fei Han has nothing to disclose.
Lixin Zhou Lixin Zhou has nothing to disclose.
Jun Ni Jun Ni has nothing to disclose.
Ming Yao Ming Yao has nothing to disclose.
Shu-Yang Zhang No disclosure on file
Zheng-Yu Jin No disclosure on file
Li-Ying Cui No disclosure on file
Yi-Cheng Zhu, MD, PhD (Peking Union Medical College Hospital) Dr. Zhu has nothing to disclose.